Skip to content
← Back to this collection

PUBLICATIONS · 34543613

Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Oct
First author
Del Mastro L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Oct;22(10):1357-1358. doi: 10.1016/S1470-2045(21)00420-4.
    note
    Source null
    related pmid
    34543612
    relationship
    Comment in

Authors and identifiers

  1. name
    Del Mastro L
    type
    Author
  2. name
    Mansutti M
    type
    Author
  3. name
    Bisagni G
    type
    Author
  4. name
    Ponzone R
    type
    Author
  5. name
    Durando A
    type
    Author
  6. name
    Amaducci L
    type
    Author
  7. name
    Campadelli E
    type
    Author
  8. name
    Cognetti F
    type
    Author
  9. name
    Frassoldati A
    type
    Author
  10. name
    Michelotti A
    type
    Author
  11. name
    Mura S
    type
    Author
  12. name
    Urracci Y
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Del Mastro L
    type
    Author
  2. name
    Mansutti M
    type
    Author
  3. name
    Bisagni G
    type
    Author
  4. name
    Ponzone R
    type
    Author
  5. name
    Durando A
    type
    Author
  6. name
    Amaducci L
    type
    Author
  7. name
    Campadelli E
    type
    Author
  8. name
    Cognetti F
    type
    Author
  9. name
    Frassoldati A
    type
    Author
  10. name
    Michelotti A
    type
    Author
  11. name
    Mura S
    type
    Author
  12. name
    Urracci Y
    type
    Author
bibliography ids
  1. nci-bib-ed6eac15d4c4fd5cb223f05f
book metadata
content sha256
df669e50181bc5cf2901330ff2a4d10f94228c3a947da7ad336c5e59f57e7621
document type
citation
dois
  1. 10.1016/S1470-2045(21)00352-1
electronic publication date
display
2021 Sep 17
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34543613
immutable id
pubmed:34543613@df669e50181bc5cf2901330ff2a4d10f94228c3a947da7ad336c5e59f57e7621
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
10
name
The Lancet. Oncology
nlm unique id
100957246
pages
1458-1467
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Oct;22(10):1357-1358. doi: 10.1016/S1470-2045(21)00420-4.
    note
    Source null
    related pmid
    34543612
    relationship
    Comment in
outcomes validated
false
pmid
34543613
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
c1c0fb0136ca1e50af98ab2c9e50bda057c0e0f9ca77dfbcbb63870350e6fd4c
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Oct
precision
month
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34543613/
title
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.

Preserved source evidence · Not medical advice